


MANUFACTURER: Dragon Pharma, Europe
ACTIVE INGREDIENT: Retatrutide
STRENGTH: 10 mg/ml
AMOUNT: vial
1. Retatrutide is an investigational peptide-based cancer immunotherapy drug designed to treat solid tumors.
2. It works by binding to and blocking the function of the TGF-β2 protein, which is involved in the regulation of cell growth and immune responses.
3. TGF-β2 often contributes to the progression of cancer by suppressing the immune system and promoting tumor growth, metastasis, and resistance to treatment.
4. By inhibiting TGF-β2, Retatrutide aims to enhance the body's natural immune response against cancer cells, making them more susceptible to destruction.
5. The drug is currently in the early stages of clinical development, with studies examining its safety and efficacy in various cancer types, including pancreatic, colorectal, and non-small cell lung cancer.
Please log in to write Retatrutide 10 mg review.